Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_assertion description "[The efficacy of the ACE (angiotensin-converting enzyme) inhibitor perindopril in coronary artery disease [EUROPA (European trial on reduction of cardiac events with perindopril in stable coronary artery disease) study] is associated with the rs12050217 A/G single nucleotide polymorphism in the B1 receptor (bradykinin type 1 receptor) gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_assertion evidence source_evidence_literature NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_assertion SIO_000772 24117346 NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_assertion wasDerivedFrom befree-20140225 NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_assertion wasGeneratedBy ECO_0000203 NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP160699.RAY_xf19NaZroDltH3OSDSfu372bST14dcpCIVyzrLtzU130_provenance.